A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Precision Spine Launches Nationally the SureLOK MIS 3L Percutaneous Screw System

Offering Surgeons Outstanding Versatility and Flexibility

The SureLOK MIS 3L Percutaneous Screw System, which provides spine surgeons with outstanding versatility and flexibility in terms of procedural approaches and application of its various components.

“The inherent versatility of the SureLOK MIS 3L System enables it to be used in Open, Mini-Open or Percutaneous MIS approaches, or even a combination of any of those approaches during the same procedure,” said Phillip Kravetz, MD, who worked with the Precision Spine design team in the development of the system. “This flexibility provides surgeons with a range of options intended to optimize efficiency and effectiveness in both planning and performing successful spinal procedures.”

“The SureLOK MIS 3L Percutaneous Screw System represents another example of how Precision Spine is making good on its commitment to develop minimally invasive devices that feature the versatility and flexibility surgeons need to help improve OR efficiency and achieve positive patient outcomes,” said Chris DeNicola, Chief Operating Officer of Precision Spine.

Component versatility is another key element of the SureLOK MIS 3L System, which consists of cannulated pedicle screws, straight and pre-curved rods, and locking caps, all of which are available in a variety of sizes that enable surgeons to more closely match each patient’s anatomy. The screws feature a 150mm Extended Tab designed to allow for low profile, MIS Percutaneous placement with 50mm of controlled rod reduction. In addition, an Open Tulip design helps ease rod introduction while the proximal tapered triple lead thread helps enhance efficiency in placing screws and optimize pull-out strength. The screw’s self-tapping tip is designed to help ease insertion and a square thread locking cap assists in reducing the potential for cross threading. The system’s easy-to-use percutaneous rod inserter features a bulleted tip, keyed hex end and 15° rod angle which helps ease rod insertion and release; the inserter shaft is designed to glide easily through the tulips for fast and efficient rod delivery. The system also includes a reliable compression/distraction system.

The indications of the SureLOK MIS 3L System provide further versatility. The system can be used in the immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine. It may also be used for non-cervical pedicle screw fixation for severe spondylolisthesis, trauma, spinal stenosis, curvatures, spinal tumor, pseudarthrosis and failed previous fusion.

“The SureLOK MIS 3L Percutaneous Screw System represents another example of how Precision Spine is making good on its commitment to develop minimally invasive devices that feature the versatility and flexibility surgeons need to help improve OR efficiency and achieve positive patient outcomes,” said Chris DeNicola, Chief Operating Officer of Precision Spine.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy